Celina Schocken isn't the kind of CEO who stays at her desk. As the head of Pink Ribbon Red Ribbon, a nonprofit dedicated to improving women's health in the developing world, Schocken [above right, with a pregnant woman in Uganda] spends almost half of her time in Africa or South America, visiting health clinics and meeting with local partners. Soon, in service to her group's cervical-cancer-screening campaign, she'll also be showing off a new gadget. Her colleagues in Africa will begin field-testing an AI-enabled tool to help clinic workers spot the early warning signs of cancer [see "AI Medicine Comes to Africa's Rural Clinics," in this issue]. The tool is now being readied for deployment by artificial intelligence researchers at Intellectual Ventures Laboratory, an innovation hub in Bellevue, Wash. Schocken cites estimates that only 5 percent of women in Africa have been screened for cervical cancer. Stigma is partially to blame, she says; some cultures believe that women who get cervical or breast cancer are being punished by the gods for unfaithfulness, while others blame witchcraft. Women often don't come in for screening until their symptoms can no longer be ignored, at which point their odds of survival are reduced. "It's similar to where we were with HIV about 15 years ago," Schocken says. "People believe that if you get it, you're going to die." [ABSTRACT FROM AUTHOR] Copyright of IEEE Spectrum is the property of IEEE and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)